Description
Anlotinib INN 12 mg, sold under the brand name, is an oral tyrosine-inlam inhibitor (TKI) for the treatment of various types of cancer. It plays an important role in inhibiting tumor growth and angiogenesis (formation of new blood vessels that provide the tumor). Anlotinib is primarily used to treat non-small cell carcinoma (NSCLC), soft tissue ARCOM, and other malignant tumors. It is known for its effectiveness in several receptor orientations and is an effective therapeutic part of oncology.
Structure and mechanism of action
Each Tower (Anlothinib Inn) 12 mg capsule contains hydrochloride salts containing -lotinib as the active ingredient. This multi-standard tyrosine-kinase inhibitor with small molecules blocks several signaling pathways involved in cancer growth.
Receptors for vascular endothelial growth factor (VEGFR 1, 2, 3) prevent angiogenesis and hunger for the required blood supply.
The fibroblast growth factor receptor (FGFR 1-4) plays a role in inhibiting tumor cell proliferation and resistance mechanisms.
It affects growth factor receptors (PDGFR±) derived from the blood plate Masu.
C-KIT and RET kinases help in controlling tumors and growth. By aligning these receptors, anlotinib effectively inhibits tumor development and reduces the risk of cancer recurrence. Adaptation and use
Non-small cell lung cancer (NSCLC)
Inhibitory is usually used in patients with progressive or metastatic NSCLC, which, previously exposed to standardized chemotherapy, causes disease. It improves progressive survival and shows promising results due to delayed tumor growth.
Soft fabric (STS)
In patients with locally advanced or metastatic soft tissue scents, especially those with chemotherapy options, we provide alternative therapy, tumor control, and fixation as well as tumor survival.
Thyroid cancer (MTC) and other types of cancer
New results demonstrate the effectiveness of allocation in the treatment of thyroid medullary carcinoma and other solid tumors, especially when angiogenesis plays an important role in cancer progression. Dosage and administration
Recommended dosage
The standard dose non-out route is 12 mg per day followed by a 7-day break (21-day cycle). If possible, you should take photos at the same time every day.
Anlotinib INN 12 Mg (Anlotib) Dose adjustment
If serious side effects or toxicity occurs, the dose can be reduced to 10 mg or 8 mg per day.
If there are serious side effects, you may need a temperament. Possible side effects
Like most targeted therapies, invasion easily causes side effects and requires careful monitoring. Frequent side effects
The antiangiogenic effect of hypertension (hypertension) requires regular blood pressure monitoring.
Fatigue and weakness – Frequent side effects in cancer treatment.
Handshake syndrome (HFS) causes redness, swelling and pain in palm trees and soles.
Diarrhea and stomach problems – Nausea to moderate nausea, vomiting, or diarrhea can occur.
Serious side effects
Cardiotoxicity affects cardiac function and requires careful monitoring. Proteinuria (excessive protein in the urine) kidney function should be checked regularly.
Bleeding or bleeding problems – Precautions must be taken for bleeding.
Thyroid dysfunction should be monitored as anilotinib can lead to hypothyroidism.
Precautions and warnings
Pregnancy and Breastfeeding – It is not recommended to use during pregnancy as it can cause fetal damage during pregnancy. Patients with severe liver or renal dysfunction should consult an oncologist before use.
Heart Health Patients – Patients with history’s heart disease should closely monitor potential cardiotoxicity.
Anlotinib INN 12 Mg (Anlotib) Interactions with drugs
Anlotinib can interact with other drugs, including:
CYP3A4 Inhibitors and Inductors – Drug therapies such as ketoconazole and rifampicin can affect metabolism through their inhibitory properties.
Blood medication – Blood pressure treatment needs to be optimiz. Anticoagulants and NSAIDs can increase the risk of bleeding. Clinical efficacy and benefits
A long study of survival rates (PFS) has shown a significant increase in anulotinib PF in patients with NSCLC and STS.
In contrast to oral convenience, Anlotib offers an oral alternative that can be easily manage.
Inhibition of three-way spectral multimultartel is effective against a wide range of cancer types by blocking important pathways involved in tumor growth.
Conclusion
Anlotinib Inn 12 mg (Anlotib) is a groundbreaking multititle tirosine-inase inhibitor that offers effective treatment options for patients with non-small cell lung cancer, soft tissue, and other malignant active ingredients. Inhibition and growth pathways of tumor angiogenesis provide significant therapeutic benefits and expand survival in patients with limited options. However, careful monitoring of side effects and compliance with dosag time planning is important to maximize efficacy and, at the same time, minimize risk.
How to order IEB Pharma medicine…
Ordering our IEB Pharma Medicines is easy. Currently there is no automated ordering system on our website; we offer various options for ordering IEB Pharma Medicines.
WhatsApp: You can send a message by clicking on our WhatsApp button, and a customer service representative of IEB Pharma will assist you in placing your order.
Telegram/Messenger/WeChat: If you want to place an order on our Facebook Messenger, Telegram, or WeChat, then you can easily place an order by clicking on our message option button.
Email: You can message us at iebpharma108@gmail for details about your order. We answer your call as soon as we can.
